Home / Products / Pharma / General / By Brand Name / Dexlan

Dexlan

Dexlansoprazole INN

NAME STRENGTH PACK SIZE DOSAGE FORM
Dexlan 30 30 mg 10X10 Capsule
Dexlan 60 60 mg 3X10 Capsule

Description

Dexlansoprazole is a PPI that suppresses gastric acid secretion by specific inhibition of the (H+, K+)-ATPase in the gastric parietal cell, resulting in potent inhibition of gastric acid secretion with prolonged elevation of intragastric pH.

Dexlan-30: Each capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets. Dexlan-60: Each capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets.

Dexlan (Dexlansoprazole) is a proton pump inhibitor used to treat- 1. Healing of all grades of erosive esophagitis 2. Maintaining healing of erosive esophagitis 3. Heart burn associated with non-erosive Gastroesophageal reflux disease (GERD)

Dexlan (Dexlansoprazole) is a proton pump inhibitor used to treat- 1. Healing of all grades of erosive esophagitis 2. Maintaining healing of erosive esophagitis 3. Heart burn associated with non-erosive Gastroesophageal reflux disease (GERD)

Side effects are rarely seen; such as diarrhea, abdominal pain, nausea, vomiting, flatulence etc

Patients taking concomitant Warfarin may require monitoring for increases in international normalized ratio (INR) and prothrombin time. Increases in INR and prothrombin time may lead to abnormal bleeding and even death.

Dexlansoprazole is considered a pregnancy Category B medication. This means that dexlansoprazole is probably safe for use during pregnancy, although the full risks are currently unknown.

Dexlan (Dexlansoprazole) may interfere with the absorption of drugs for which gastric pH is important for bioavailability (e.g., Ampicillin esters, Digoxin, iron salts, Ketoconazole).

There have been no reports of significant overdose of Dexlansoprazole. It is not expected to be removed from the circulation by hemodialysis. If an overdose occurs, treatment should be symptomatic and supportive.

Store in a cool and dry place. Keep away from light and out of reach of children.

Dexlan (Dexlansoprazole) is contraindicated in patients with known hypersensitivity to any component of the formulation. Hypersensitivity and anaphylaxis have been reported with Dexlansoprazole

Dexlan-30: Each commercial box contains 10X10 capsules of Dexlansoprazole INN 30 mg as enteric coated pellets. Dexlan-60: Each commercial box contains 3X10 capsules of Dexlansoprazole INN 60 mg as enteric coated pellets.